/clinical/,/clinical/tools-resources/,/clinical/tools-resources/lab-test-directory/,/clinical/tools-resources/lab-test-directory/molecular-diagnostics/,

/clinical/tools-resources/lab-test-directory/molecular-diagnostics/name-68815-en.labtest

Jun 14, 2017

page

100

UWHC,UWMF,

Clinical Hub,Tools & Resources,UWHC Lab Test Directory,Molecular Diagnostics

STR Engraftment Unseparated Lineages, Bone Marrow

STR Engraftment Unseparated Lineages, Bone Marrow (HCSTREBM) Molecular Diagnostics Lab Test

Name: STR Engraftment Unseparated Lineages, Bone Marrow

Test Name: STR Engraftment Unseparated Lineages, Bone Marrow

Health Link Test Code: HCSTREBM

LIS Test Code: STREBM

CPT Code(s): 81267

Methodology: PCR

Clinical Information:

Typically used to assess proportions of donor and recipient derived nucleated cells post stem cell transplant or in cases of suspected graft-vs-host disease.

Days Performed: Wed.

In-Lab Turnaround Time: 10 days.

Specimen: Bone marrow aspirate

Collection Container: Lavender top

Collection Volume: 1 mL

Pediatric Collection Volume: 1 mL

Stability Ambient:

7 days

Stability Refridgerated:

3 weeks

Stability Frozen:

Not acceptable

Sample Analyzed: Bone Marrow Aspirate

Testing Volume: 1 mL

Pediatric Testing Volume: 0.6 mL

Specimen Transport:

Transport specimen to Laboratory.

Interpretation:

 

 >95% Donor DNA:  Predominantly Donor
 < 5% Donor DNA:  Predominantly Recipient
 5-95% Donor DNA:  Donor/Recipient Chimeric

    

Additional Information:

Test requires pre-transplant DNA samples on file in the laboratory for recipient and donor.

 

The performance characteristics of this test were validated by UWHC Clinical Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The UWHC Clinical Laboratories is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.